452 related articles for article (PubMed ID: 27130670)
1. Immunization against pertussis in adolescents and adults.
Esposito S; Principi N;
Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S89-S95. PubMed ID: 27130670
[TBL] [Abstract][Full Text] [Related]
2. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
[TBL] [Abstract][Full Text] [Related]
3. Pertussis immunisation in adolescents and adults--Bordetella pertussis epidemiology should guide vaccination recommendations.
Heininger U; Cherry JD
Expert Opin Biol Ther; 2006 Jul; 6(7):685-97. PubMed ID: 16805708
[TBL] [Abstract][Full Text] [Related]
4. Rationale for pertussis booster vaccination throughout life in Europe.
Zepp F; Heininger U; Mertsola J; Bernatowska E; Guiso N; Roord J; Tozzi AE; Van Damme P
Lancet Infect Dis; 2011 Jul; 11(7):557-70. PubMed ID: 21600850
[TBL] [Abstract][Full Text] [Related]
5. Control of pertussis in the world.
Galazka A
World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults.
Nitsch-Osuch A; Korzeniewski K; Kuchar E; Zielonka T; Życińska K; Wardyn K
Respir Physiol Neurobiol; 2013 Jun; 187(1):99-103. PubMed ID: 23419520
[TBL] [Abstract][Full Text] [Related]
7. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].
Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L
Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362
[TBL] [Abstract][Full Text] [Related]
8. Neonatal pertussis, cocooning and maternal immunization.
Swamy GK; Wheeler SM
Expert Rev Vaccines; 2014 Sep; 13(9):1107-14. PubMed ID: 25075629
[TBL] [Abstract][Full Text] [Related]
9. Pertussis: Where did we go wrong and what can we do about it?
Locht C
J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
[TBL] [Abstract][Full Text] [Related]
10. Controlling pertussis: how can we do it? A focus on immunization.
Martinón-Torres F; Heininger U; Thomson A; Wirsing von König CH
Expert Rev Vaccines; 2018 Apr; 17(4):289-297. PubMed ID: 29482390
[TBL] [Abstract][Full Text] [Related]
11. Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.
Salim AM; Liang Y; Kilgore PE
Paediatr Drugs; 2015 Dec; 17(6):425-41. PubMed ID: 26542059
[TBL] [Abstract][Full Text] [Related]
12. The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010.
Guiso N; Liese J; Plotkin S
Hum Vaccin; 2011 Apr; 7(4):481-8. PubMed ID: 21389775
[TBL] [Abstract][Full Text] [Related]
13. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
[TBL] [Abstract][Full Text] [Related]
14. Whooping cough, twenty years from acellular vaccines introduction.
Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A
Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141
[TBL] [Abstract][Full Text] [Related]
15. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.
Scott LJ
BioDrugs; 2010 Dec; 24(6):387-406. PubMed ID: 21043546
[TBL] [Abstract][Full Text] [Related]
16. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine.
Lavine JS; Bjørnstad ON; de Blasio BF; Storsaeter J
Vaccine; 2012 Jan; 30(3):544-51. PubMed ID: 22119924
[TBL] [Abstract][Full Text] [Related]
17. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations.
Forsyth K; Nagai M; Lepetic A; Trindade E
Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S93-7. PubMed ID: 15876935
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
Kurova N; Timofeeva EV; Guiso N; Macina D
Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
[TBL] [Abstract][Full Text] [Related]
19. [Global pertussis epidemiology and immunization strategies].
Zhang WH
Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):467-72. PubMed ID: 20084979
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of routine and booster pertussis vaccination in children and adolescents, federal state of Brandenburg, Germany, 2002-2012.
Haller S; Dehnert M; Karagiannis I; Rieck T; Siffczyk C; Wichmann O; Poethko-Mueller C; Hellenbrand W
Pediatr Infect Dis J; 2015 May; 34(5):513-9. PubMed ID: 25621762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
